Skip to main content

McKesson Value Stock - Dividend - Research Selection

Mckesson

ISIN: US58155Q1031 , WKN: 893953

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


McKesson Corp. stock outperforms competitors on strong trading day

2025-01-23
McKesson Corp. stock outperforms competitors on strong trading day

McKesson Corp. stock underperforms Tuesday when compared to competitors

2025-01-21
McKesson Corp. stock underperforms Tuesday when compared to competitors

McKesson Seems Cheap, But Risks Linger

2025-01-21
McKesson's stock appears undervalued, trading at 18 times forward earnings and free cash flow. See why MCK is a Hold.

Should Value Investors Buy CONMED (CNMD) Stock?

2025-01-08
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

2025-01-08
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

McKesson Amplify Empowers State Pharmacy Associations Nationwide with Advocacy Funding

2025-01-08
IRVING, Texas - Guided by McKesson's core belief that the patient comes first, McKesson Amplify is a strategic initiative intended to help protect critical pharmacy services and elevate the pharmacy...

McKesson (MCK) Gains As Market Dips: What You Should Know

2025-01-07
McKesson (MCK) concluded the recent trading session at $585.24, signifying a +0.83% move from its prior day's close.

Pro-Dex Stock Skyrockets Over the Past Year: A Must Buy?

2025-01-07
Investors can consider investing in PDEX right now as the stock has done extremely well through 2024 and its prospects continue to shine.

McKesson Corp. stock rises Monday, still underperforms market

2025-01-06
McKesson Corp. stock rises Monday, still underperforms market

McKesson Corp. stock underperforms Thursday when compared to competitors

2025-01-02
McKesson Corp. stock underperforms Thursday when compared to competitors